Search
for
Sort by
Research 61–90 of 1000+
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- Review of Promising Off-Label Use of Deucravacitinib
- Patient-Reported Flare Symptoms Following COVID-19 Vaccination in Systemic Lupus Erythematosus
- Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- Adherence patterns to medications and their association with subsequent hospitalization in adult Egyptian patients with systemic lupus erythematosus
- Comparative advantage and efficacy of natural products for polycystic ovary syndrome
- Microneedles as an Emerging Platform for Transdermal Delivery of Phytochemicals
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- P44 An acutely unwell and rare presentation of systemic lupus erythematosus; a case report
- Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- 571 Role of observation for excisionally biopsied moderately dysplastic nevi with positive histologic margins and risk of development of future melanoma
- Navigating Rhupus Complexity
- Navigating Rhupus Complexity
- Janus Kinase inhibitors in dermatology: a review
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Acne and acneiform eruptions
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- Subject Index
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- FRI0157 OBSERVATIONAL STUDY OF HAIR FALL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH LOW DOSE METHOTREXATE COMPARED TO HEALTHY CONTROLS
- 0282 Effect of systemic immunomodulators on incidence of alopecia areata: A retrospective cohort study
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Telitacicept for systemic lupus erythematosus with post‑surgical papillary thyroid carcinoma: A case report
- Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus